Trubion Pharma (TRBN) Posts Q3 Loss of 33c, Beats Street by 10c; Cuts Burn Rate
More News related to TRBN
- Trubion Pharma (TRBN) CEO Peter Thompson Resigns
- Trubion Pharmaceuticals (TRBN) Announces Retirement of Chairman/CEO
- Trubion Pharmaceuticals, Inc. Announces Transition in Company Leadership
- Trubion Pharma (TRBN) Announces Two Presentations of TRU-016 Product at 2009 ASH Meeting
- Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual Meeting
Trubion Pharmaceuticals, Inc (NASDAQ: TRBN) reports Q3 adjusted loss of $0.33, 10 cents better than the analyst estimate of ($0.43). Revenue for the quarter was $4.5 million, which compares to the estimate of $4.98 million.
Cuts forecast for year burn rate from $30 - $35 million, to $0 - $5 million, reaffirms FY09 outlook for sales.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.19Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
